FindMyKOL
Clinical trialNCT02435550TerminatedInterventional

iCare for Cancer Patients

SponsorUniversity of FloridaEnrollment136Acute Lymphoid LeukemiaAcute Myelogenous LeukemiaAcute Myeloid LeukemiaLeukemia, Acute LymphoblasticMultiple MyelomaMyelodysplastic Syndromes+1 more conditions
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to use genomic information from individual patients to create simulation avatars that will be used to predict novel drug combinations with therapeutic potential.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Uf Health Shands Cancer Hospital

    Gainesville, Florida, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
26 Jun 2015
Primary completion
1 Oct 2019
Completion
1 Oct 2019
Last update posted
20 Dec 2019
Registered enrollment
136
Registry id
NCT02435550

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 4 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.